The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in adolescents aged 13 to 17 years.

US researchers have engineered a novel gene therapy to target the airway and lungs via a nasal spray. For gene therapy to ...

Dong-A Pharmaceutical has introduced Co. & One Qnazal Spray, a nasal spray containing a combination of xylomethazoline and ...